LEADER 01578nas  2200553-a 450 
001 996336049403316
005 20230214213019.0
011   $a1476-5500
035   $a(DE-599)ZDB2004200-0
035   $a(OCoLC)42895504
035   $a(CKB)954925568785
035   $a(CONSER)--2008242167
035   $a(EXLCZ)99954925568785
100   $a19991129a19949999  s--            -
101 0 $aeng
135   $aurmnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aCancer gene therapy
210   $a[Houndmills, Basingstoke, Hampshire, UK] $cStockton Press
215   $a1 online resource
300   $aRefereed/Peer-reviewed
311   $a0929-1903 
531   $aCANCER GENE THER
531   $aCANC GENE T
606   $aCancer$xGene therapy$vPeriodicals
606   $aGene therapy$vPeriodicals
606   $aGenetic Therapy
606   $aNeoplasms$xtherapy
606   $aGenetics & Genomics$2ebps
606   $aOncology$2ebps
606   $aCancer$xGene therapy$2fast$3(OCoLC)fst00845367
606   $aGene therapy$2fast$3(OCoLC)fst00939638
608   $aPeriodical.
608   $aPeriodicals.$2fast
615  0$aCancer$xGene therapy
615  0$aGene therapy
615  2$aGenetic Therapy.
615  2$aNeoplasms$xtherapy.
615  7$aGenetics & Genomics.
615  7$aOncology.
615  7$aCancer$xGene therapy.
615  7$aGene therapy.
676   $a616.99406
906   $aJOURNAL
912   $a996336049403316
996   $aCancer gene therapy$9796651
997   $aUNISA